Sundance
THE age of “” is upon us – in case you hadn’t noticed. Work that could transform healthcare is under way, yet the results don’t appear in peer-reviewed journals.
This issue has been brought to the fore by the case of Silicon Valley biotech firm . Its consumer blood test, combined with innovative lab technology, promise fast, accurate results relevant to dozens of illnesses, using pinprick samples, and at low cost.
Not so long ago, I warmly applauded Theranos for seeking clearance from the US Food and Drug Administration for its proprietary diagnostic tests, but cautioned that FDA clearance…
